We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+13.39%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.86B
AUM Growth
+$57.6M
Cap. Flow
-$111M
Cap. Flow %
-5.98%
Top 10 Hldgs %
84.04%
Holding
49
New
Increased
2
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$26.5M
2
CRWD icon
CrowdStrike
CRWD
+$16.7M

Top Sells

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$74.7M
2
HOOD icon
Robinhood
HOOD
+$40.2M
3
PRME icon
Prime Medicine
PRME
+$19.9M
4
ME
23andMe Holding Co
ME
+$15.4M
5
DXCM icon
DexCom
DXCM
+$4.5M

Sector Composition

Rank Sector Weight
1 Healthcare 51.26%
2 Technology 40.71%
3 Industrials 6.58%
4 Consumer Staples 1.07%
5 Financials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERA icon
26
Vera Therapeutics
VERA
$2.37B
$4.84M 0.26%
301,580
FHTX icon
27
Foghorn Therapeutics
FHTX
$286M
$3.53M 0.19%
500,901
BRNS
28
Barinthus Biotherapeutics
BRNS
$24M
$3.12M 0.17%
1,513,644
TCRX icon
29
TScan Therapeutics
TCRX
$49.6M
$2.69M 0.14%
1,077,080
DNTH icon
30
Dianthus Therapeutics
DNTH
$5.75B
$2.54M 0.14%
208,696
KRON
31
DELISTED
Kronos Bio
KRON
$2.47M 0.13%
1,438,232
EXAS
32
DELISTED
Exact Sciences
EXAS
$2.18M 0.12%
23,205
HYPR icon
33
Hyperfine
HYPR
$90.7M
$1.93M 0.1%
898,720
RANI icon
34
Rani Therapeutics
RANI
$96.8M
$1.85M 0.1%
448,492
AUTL
35
Autolus Therapeutics
AUTL
$383M
$1.66M 0.09%
698,262
SPRO icon
36
Spero Therapeutics
SPRO
$69.5M
$1.29M 0.07%
889,979
ALEC icon
37
Alector
ALEC
$173M
$1.06M 0.06%
175,866
SNCE
38
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$674K 0.04%
160,363
OPRT icon
39
Oportun Financial
OPRT
$264M
$566K 0.03%
94,788
TSHA icon
40
Taysha Gene Therapies
TSHA
$1.65B
$423K 0.02%
640,882
QNCX icon
41
Quince Therapeutics
QNCX
$21.5M
$286K 0.02%
946
NVTA
42
DELISTED
Invitae Corporation
NVTA
$266K 0.01%
235,606
EVLO
43
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$172K 0.01%
53,024
-1
-0% -$3
MOND
44
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$164K 0.01%
18,420
RGEN icon
45
Repligen
RGEN
$6.95B
$54.2K ﹤0.01%
383
FULC icon
46
Fulcrum Therapeutics
FULC
$246M
$47.1K ﹤0.01%
14,262
HLTH
47
DELISTED
Cue Health Inc. Common Stock
HLTH
$9.99K ﹤0.01%
27,000
DUOL icon
48
Duolingo
DUOL
$6.6B
-523,824
Closed -$74.7M
ME
49
DELISTED
23andMe Holding Co
ME
-336,839
Closed -$15.4M

Similar funds

Alphabet Inc's Q2 2023 Portfolio in Review

As of Q2 2023, Alphabet Inc held 49 positions worth $1.86B, up 3.2% from $1.8B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Alphabet Inc withdrew a net $111M in Q2 2023, closing 2 positions and reducing 4 holdings. Its most notable exit was Duolingo, an estimated $74.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alphabet Inc added an estimated $26.5M to GitLab.

  • Alphabet Inc added most to GitLab in Q2 2023, an estimated $26.5M increase.
  • Alphabet Inc's biggest Q2 2023 reduction was Robinhood, cutting an estimated $40.2M.
  • Alphabet Inc fully exited Duolingo in Q2 2023, selling an estimated $74.7M.
  • Alphabet Inc's ten largest holdings make up 84% of its $1.86B portfolio in Q2 2023.
  • Alphabet Inc opened 0 new positions and closed 2 in Q2 2023.
  • Alphabet Inc's portfolio value rose 3.2% quarter-over-quarter to $1.86B.

Based on Alphabet Inc's 13F filing for Q2 2023, filed 4 Aug 2023.